Thermo Fisher Scientific
TMO
2,488 hedge funds and large institutions have $188B invested in Thermo Fisher Scientific in 2023 Q4 according to their latest regulatory filings, with 290 funds opening new positions, 884 increasing their positions, 984 reducing their positions, and 132 closing their positions.
120% more first-time investments, than exits
New positions opened: 290 | Existing positions closed: 132
18% more call options, than puts
Call options by funds: $1.92B | Put options by funds: $1.64B
9% more capital invested
Capital invested by funds: $173B → $188B (+$15.2B)
5% more funds holding
Funds holding: 2,365 → 2,488 (+123)
3.27% more ownership
Funds ownership: 88.54% → 91.82% (+3.3%)
1% more funds holding in top 10
Funds holding in top 10: 139 → 141 (+2)
10% less repeat investments, than reductions
Existing positions increased: 884 | Existing positions reduced: 984
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.14B |
| 2 |
LP
Longview Partners
St Peter Port,
Guernsey
|
+$567M |
| 3 |
State Street
Boston,
Massachusetts
|
+$404M |
| 4 |
VAM
Veritas Asset Management
London,
United Kingdom
|
+$338M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$304M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$1.08B |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$1.05B |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$654M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$419M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$325M |
TMO Hedge Fund Activity: Q4 2023 in Review
2,488 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2023, worth a combined $188B — up 8.8% from $173B a quarter earlier.
Buyers outnumbered sellers: 290 funds opened new TMO positions and 132 closed out — a net gain of 158 holders — while 884 added to existing stakes and 984 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $6.14B. The largest seller was Massachusetts Financial Services, cutting an estimated $1.08B.
- 2,488 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2023, up from 2,365 in Q3 2023.
- Funds reported $188B of Thermo Fisher Scientific stock for Q4 2023, up 8.8% quarter-over-quarter.
- 290 funds opened new Thermo Fisher Scientific positions in Q4 2023 and 132 closed out, a net change of +158 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2023 was Morgan Stanley, an estimated $6.14B added.
- The largest Thermo Fisher Scientific seller in Q4 2023 was Massachusetts Financial Services, an estimated $1.08B sold.
Based on aggregated 13F filings for Q4 2023.